Loading insider details...
Beta
Latest Form 4 (Jul 28, 2026): Grant/Award of 100,000 BCLI shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 28, 2026 | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | Grant/Award | 100,000 | n/a |
| May 29, 2026 | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | Grant/Award | 200,000 | n/a |
| Jan 3, 2025 | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | Grant/Award | 40,000 | n/a |
| Apr 8, 2022 | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | Grant/Award | 50,000 | n/a |
| Dec 10, 2021 | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | Grant/Award | 50,000 | n/a |
| Apr 7, 2020 | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | Grant/Award | 50,000 | n/a |